5 employees
OncoSynergy improves outcomes for patients with unmet needs in oncology with resistance mechanism inhibitors.
2011
$20M
from 1 investors over 1 rounds
OncoSynergy raised $20M on May 4, 2018
Investors: Korea Information & Communication Co Ltd